Frequently Asked Questions

Zero confirmed deaths from kratom alone. FDA's widely cited death reports were all polysubstance cases involving fentanyl, heroin, cocaine, benzodiazepines, or other drugs. When challenged, FDA admitted they couldn't confirm kratom as cause of death in any case. Compare to 500+ daily deaths from FDA-approved opioids. Learn More

Johns Hopkins, University of Florida, and international research consistently show kratom's excellent safety profile: low addiction potential (3-6% experience mild withdrawal), no respiratory depression, minimal organ toxicity, and significantly safer than prescription opioids. FDA systematically ignored or dismissed these peer-reviewed studies. Learn More

No. FDA uses misleading framing by calling kratom an "opioid," but kratom alkaloids are partial agonists with a ceiling effect—meaning they cannot cause respiratory depression or overdose death like true opioids. This is why there are zero confirmed kratom-alone deaths despite millions of daily users. Learn More

Yes, documented manipulation includes: counting polysubstance deaths as 'kratom deaths', ignoring toxicology showing lethal fentanyl levels, cherry-picking cases while excluding exculpatory evidence, and using unverified FAERS reports without investigation. FDA's own scientists called out these methods as scientifically invalid. Learn More

The nocebo effect is when negative expectations create real negative outcomes. If you're told a substance will cause anxiety, nausea, or addiction—and you believe it—your brain can produce those exact symptoms even when the substance itself wouldn't cause them. It's the evil twin of the placebo effect. Learn More

Yes. Fear-based messaging primes users to expect negative outcomes, which can manifest as real symptoms through the nocebo effect. This creates a self-fulfilling prophecy: propaganda warns of danger → users experience nocebo-induced symptoms → symptoms "confirm" the propaganda. Understanding this mechanism breaks its power. Learn More

Multiple factors: nocebo effect from fear messaging, prior opioid dependence (attributed to kratom), extremely high doses beyond normal use, and genuine mild withdrawal in 3-6% of users. The nocebo effect amplifies actual symptoms—expectation of severe withdrawal can make mild discomfort feel catastrophic. Learn More

Awareness is the antidote. When you understand the nocebo mechanism, you can recognize fear-based framing and separate real pharmacological effects from expectation-induced symptoms. Focus on evidence-based information, understand actual risk profiles, and don't catastrophize normal experiences. Learn More

Over $258 billion annually across threatened markets: $89B pain management, $67B mental health medications, $42B addiction treatment, $38B stimulants/ADHD drugs, $22B sleep medications. Every kratom user managing pain, anxiety, or opioid recovery without pharmaceuticals is lost revenue across multiple profit centers. Learn More

Yes, 45% of FDA's budget ($2.9 billion of $6.5 billion total in 2023) comes from pharmaceutical company user fees. The companies being regulated are literally paying the regulator's salary. This creates obvious incentive to approve pharmaceutical drugs and suppress competition like kratom that threatens industry revenue. Learn More

You can't patent a plant. Pharmaceutical business model requires patents to monopolize drugs and charge premium prices. Natural kratom costs $50/month—they can't compete with that. Their strategy: ban natural kratom, develop patented synthetic versions of kratom alkaloids, charge $300-500/month with no natural competition. Learn More

Between $75-150 million annually on coordinated anti-kratom campaigns including lobbying, PR firms, paid influencers, astroturfing, and media manipulation. This is documented through lobbying disclosures, influencer payment receipts, and coordinated propaganda campaigns. The spending proves this is about protecting profits, not public health. Learn More

Yes, the revolving door is well-documented. Former FDA Commissioner Scott Gottlieb joined Pfizer's board after aggressively opposing kratom during his tenure. Multiple FDA officials have taken lucrative pharmaceutical board positions within months of leaving the agency. This creates obvious incentive to favor pharmaceutical interests while at FDA. Learn More

Extensively. FDA ignored: NIDA-funded safety studies, University of Florida pharmacology research, Johns Hopkins survey data, international clinical experience, and even their own 8-Factor Analysis showing kratom doesn't meet criteria for scheduling. Any research contradicting prohibition narrative was systematically excluded from policy decisions. Learn More

The 8-Factor Analysis is FDA/DEA's own scientific framework for evaluating scheduling substances. When properly applied to kratom, it showed: low abuse potential, minimal public health risk, established medical benefit, and significantly safer profile than scheduled drugs. FDA buried these findings and proceeded with prohibition attempts anyway. Learn More

Check: funding sources (pharma-funded studies show bias), author conflicts of interest, sample size and methodology, whether limitations are disclosed, if opposing research is cited, and whether conclusions match the actual data. Studies designed to produce predetermined results have telltale patterns once you know what to look for. Learn More

Common tricks: reporting relative risk without absolute risk, cherry-picking timeframes, using unverified self-reported data, attributing polysubstance effects to kratom alone, comparing worst-case kratom scenarios to best-case pharmaceutical scenarios, and using correlation to imply causation. Media literacy is your defense. Learn More

Yes, documented through payment receipts, PR firm contracts, and coordination patterns. Major anti-kratom campaigns feature paid influencers receiving $5,000-25,000 per campaign to spread fear stories, tragic testimonials, and prohibition talking points. The coordination is obvious: identical messaging, synchronized timing, professional media kits. Learn More

Astroturfing is creating fake grassroots movements using paid actors. Anti-kratom astroturfing includes: fake parent advocacy groups funded by pharma, coordinated social media accounts posting identical content, manufactured crisis stories, paid testimonials disguised as organic experiences, and PR firms orchestrating everything while hiding funding sources. Learn More

Many are fabricated or misrepresented. Investigation reveals: stock photos used for 'victims', deaths actually caused by fentanyl/polydrug use blamed on kratom, paid actors giving testimonials, crisis PR firms crafting emotional narratives, and coordination with media to amplify unverified stories. Real tragedies are exploited and exaggerated for prohibition agenda. Learn More

Red flags include: identical messaging across multiple accounts, synchronized timing, professional media production, emotional manipulation, vague sourcing, connection to PR firms, funding opacity, and coordination with policy pushes. Real grassroots movements show organic growth, diverse messaging, and transparent funding. Astroturf shows corporate fingerprints. Learn More

ChatGPT was trained on internet data heavily polluted with FDA propaganda, pharmaceutical PR campaigns, and astroturfed content. The training data overrepresents anti-kratom misinformation while underrepresenting peer-reviewed research and user experiences. Result: AI reproduces prohibition narrative as if it's factual consensus when it's actually manufactured propaganda. Learn More

Use specific prompting techniques: Request peer-reviewed sources only, ask for conflicting evidence, demand numerical context (compare kratom risks to FDA-approved drugs), specify you want pharmacological facts not policy positions, and explicitly ask AI to separate science from propaganda. Detailed bypass prompts provided in full article. Learn More

Already happening. Investigation reveals AI-generated anti-kratom content flooding social media, AI-written 'studies' with fabricated citations, chatbots programmed to discourage kratom use, and AI-powered astroturfing creating thousands of fake anti-kratom accounts. AI makes propaganda cheaper and more scalable than ever before. Learn More

Yes, unless corrected. As AI systems train on AI-generated content (recursive training), bias compounds. AI outputs become training data for next generation, creating echo chambers of misinformation. Plus pharmaceutical industry actively targeting AI training with sponsored content. Fight back by creating accurate, well-sourced kratom content to balance the training ecosystem. Learn More

Identical tactics across 90 years: fabricated death statistics, racist undertones targeting immigrant communities, pharmaceutical industry lobbying, moral panic campaigns, cherry-picked science, ignoring medical benefits, and emergency scheduling attempts. Even the propaganda language is recycled—compare 'reefer madness' headlines to modern 'kratom crisis' coverage. Learn More

Yes, documented parallels: Cannabis was called 'deadly', blamed for murders and insanity, claimed to cause instant addiction, and targeted with fabricated death reports—all later proven false. Kratom faces identical false claims today: exaggerated deaths (all polysubstance), addiction fears (3-6% experience mild withdrawal), and ignored safety profile. History repeating exactly. Learn More

80+ years from 1937 prohibition to current state-level legalization, and still federally illegal. The lesson for kratom: prohibition is easy to implement but extremely difficult to reverse, even when proven wrong. Decades of lives destroyed, medical benefits denied, and economic opportunity lost before policy catches up to science. Prevention is critical. Learn More

Key lessons: grassroots organizing works but takes decades, state-level victories can prevent federal prohibition, economic arguments sway legislators, patient testimonials humanize the issue, and scientific research eventually overcomes propaganda. Also: never stop fighting—prohibition advocates never give up, so neither can we. Learn More

Phase 1: Demonization—spread fear through media, fabricate crisis, create moral panic. Phase 2: Emergency Scheduling—claim urgent threat requiring immediate ban bypassing normal process. Phase 3: Permanent Prohibition—make temporary ban permanent through legislation. This exact playbook has been used against cannabis, psychedelics, and now kratom. Learn More

Concrete actions: Contact legislators with personal testimony and science, organize kratom users for coordinated advocacy, attend public hearings, partner with American Kratom Association, build relationships with local media, support Kratom Consumer Protection Act (regulation not prohibition), and mobilize quickly when bans are proposed. Numbers matter—legislators respond to constituent pressure. Learn More

Model legislation establishing quality standards, age restrictions, labeling requirements, and Good Manufacturing Practices for kratom—regulating the market rather than banning it. Passed in several states as compromise preventing prohibition while addressing legitimate safety concerns. The smart alternative to outright bans. Learn More

Yes, multiple victories: DEA withdrew federal emergency scheduling in 2016 after massive pushback, numerous state bans defeated through organized advocacy, and several states passed Kratom Consumer Protection Act instead of prohibition. Grassroots organizing works—but requires sustained effort, strategic coordination, and thousands of voices. Your participation matters. Learn More

Yes, in most jurisdictions it's legal to purchase and stockpile kratom while it remains legal. Most ban laws only prohibit purchase, sale, and possession after the effective date—not possession of kratom acquired legally before the ban. However, check your specific state's proposed language, as some bans include retroactive possession penalties. Buy before any ban takes effect. Learn More

It depends on state laws. Kratom is federally legal, so interstate transport is legal federally—but illegal if you enter a state where kratom is banned (Alabama, Arkansas, Indiana, Rhode Island, Vermont, Wisconsin, plus some counties/cities). Never travel through or to ban states with kratom. For air travel to legal states: keep kratom in original packaging, carry documentation, and know TSA can't confiscate federally legal substances. Learn More

No. Standard 5, 10, or 12-panel drug tests don't screen for kratom alkaloids (mitragynine/7-hydroxymitragynine). Kratom requires a specialized test specifically looking for its alkaloids—these are rare and expensive. However, some specialized employment (DOT, federal, military) may use extended panels. If concerned, ask employer what specific test is used. Learn More

Immediate actions: stockpile legal supply before effective date, document all purchases with receipts, organize with other users to fight ban, explore relocation to kratom-legal state if using medicinally, investigate safe alternatives, and prepare gradual taper if needed. Long term: continue advocacy work, support legal challenges, and work toward reversal. Many state bans have been overturned through persistent advocacy. Learn More

Contact your state legislators. Phone calls are most effective—a single 2-minute call carries more weight than 100 emails. Tell your personal story, identify yourself as a constituent and voter, and request support for Kratom Consumer Protection Act. Legislators respond to constituent pressure—your voice matters more than you think. Learn More

Absolutely. Simple actions create massive collective impact: share kratom truth on social media (5 min), contact one legislator monthly (2 min), donate $10 to American Kratom Association, educate one person about kratom facts, or leave positive kratom vendor reviews. You don't need to be an expert—authentic personal testimony from regular users is the most powerful advocacy tool. Learn More

American Kratom Association (AKA) is the primary national advocacy organization—they lead legislative fights, coordinate grassroots campaigns, and fund research. Botanical Education Alliance provides education resources. Support with donations, volunteer time, or simply sharing their action alerts. AKA has successfully defeated numerous state bans and led DEA emergency scheduling withdrawal. Learn More

No—bans can be reversed. Multiple states have overturned kratom bans through persistent advocacy: Nevada repealed its ban, several counties reversed local prohibitions, and ongoing efforts in banned states show progress. Plus your advocacy prevents federal prohibition affecting all states. Even in banned states: support national organizations, share truth online, and prepare for reversal campaigns. Change takes time but happens. Learn More